CD161 is a marker of all human IL17 producing T cell subsets, and it is also a pan-cancer prognostic factor with favoring outcome (23, 24), and these inhibitory function of RFA over T cells could be eliminated by removal of serum components which is bigger than 10KD. This evidence concerns the gene IL17A and cancer.